Loading...

Vicki L Wheelock

Title(s)Professor, Neurology
SchoolUniversity of California, Davis
Phone916-734-6287
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Yuan M, Sperry L, Malhado-Chang N, Duffy A, Wheelock V, Farias S, O'Connor K, Olichney J, Shahlaie K, Zhang L. Atypical antipsychotic therapy in Parkinson's disease psychosis: A retrospective study. Brain Behav. 2017 06; 7(6):e00639. PMID: 28638698.
      View in: PubMed
    2. McGarry A, McDermott M, Kieburtz K, de Blieck EA, Beal F, Marder K, Ross C, Shoulson I, Gilbert P, Mallonee WM, Guttman M, Wojcieszek J, Kumar R, LeDoux MS, Jenkins M, Rosas HD, Nance M, Biglan K, Como P, Dubinsky RM, Shannon KM, O'Suilleabhain P, Chou K, Walker F, Martin W, Wheelock VL, McCusker E, Jankovic J, Singer C, Sanchez-Ramos J, Scott B, Suchowersky O, Factor SA, Higgins DS, Molho E, Revilla F, Caviness JN, Friedman JH, Perlmutter JS, Feigin A, Anderson K, Rodriguez R, McFarland NR, Margolis RL, Farbman ES, Raymond LA, Suski V, Kostyk S, Colcher A, Seeberger L, Epping E, Esmail S, Diaz N, Fung WL, Diamond A, Frank S, Hanna P, Hermanowicz N, Dure LS, Cudkowicz M. A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. Neurology. 2017 Jan 10; 88(2):152-159. PMID: 27913695.
      View in: PubMed
    3. Fink KD, Deng P, Gutierrez J, Anderson JS, Torrest A, Komarla A, Kalomoiris S, Cary W, Anderson JD, Gruenloh W, Duffy A, Tempkin T, Annett G, Wheelock V, Segal DJ, Nolta JA. Allele-Specific Reduction of the Mutant Huntingtin Allele Using Transcription Activator-Like Effectors in Human Huntington's Disease Fibroblasts. Cell Transplant. 2016; 25(4):677-86. PMID: 26850319.
      View in: PubMed
    4. Pollock K, Dahlenburg H, Nelson H, Fink KD, Cary W, Hendrix K, Annett G, Torrest A, Deng P, Gutierrez J, Nacey C, Pepper K, Kalomoiris S, D Anderson J, McGee J, Gruenloh W, Fury B, Bauer G, Duffy A, Tempkin T, Wheelock V, Nolta JA. Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models. Mol Ther. 2016 05; 24(5):965-77. PMID: 26765769.
      View in: PubMed
    5. Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, Siemers E, Tanner C, Mallonee W, Suter G, Dubinsky R, Gray C, Nance M, Bundlie S, Radtke D, Kostyk S, Baic C, Caress J, Walker F, Hunt V, O'Neill C, Chouinard S, Factor S, Greenamyre T, Wood-Siverio C, Corey-Bloom J, Song D, Peavy G, Moskowitz C, Wesson M, Samii A, Bird T, Lipe H, Blindauer K, Marshall F, Zimmerman C, Goldstein J, Rosas D, Novak P, Caviness J, Adler C, Duffy A, Wheelock V, Tempkin T, Richman D, Seeberger L, Albin R, Chou KL, Racette B, Perlmutter JS, Perlman S, Bordelon Y, Martin W, Wieler M, Leavitt B, Raymond L, Decolongon J, Clarke L, Jankovic J, Hunter C, Hauser RA, Sanchez-Ramos J, Furtado S, Suchowersky O, Klimek ML, Guttman M, Sethna R, Feigin A, Cox M, Shannon B, Percy A, Dure L, Harrison M, Johnson W, Higgins D, Molho E, Nickerson C, Evans S, Hobson D, Singer C, Galvez-Jimenez N, Shannon K, Comella C, Ross C, Saint-Hilaire MH, Testa C, Rosenblatt A, Hogarth P, Weiner W, Como P, Kumar R, Cotto C, Stout J, Brocht A, Watts A, Eberly S, Weaver C, Foroud T, Gusella J, MacDonald M, Myers R, Fahn S, Shults C. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials. JAMA Neurol. 2016 Jan; 73(1):102-10. PMID: 26569098.
      View in: PubMed
    6. Carvalho JO, Long JD, Westervelt HJ, Smith MM, Bruce JM, Kim JI, Mills JA, Paulsen JS. The impact of oculomotor functioning on neuropsychological performance in Huntington disease. J Clin Exp Neuropsychol. 2016; 38(2):217-26. PMID: 26745770.
      View in: PubMed
    7. Long JD, Paulsen JS. Multivariate prediction of motor diagnosis in Huntington's disease: 12 years of PREDICT-HD. Mov Disord. 2015 Oct; 30(12):1664-72. PMID: 26340420.
      View in: PubMed
    8. Matsui JT, Vaidya JG, Wassermann D, Kim RE, Magnotta VA, Johnson HJ, Paulsen JS. Prefrontal cortex white matter tracts in prodromal Huntington disease. Hum Brain Mapp. 2015 Oct; 36(10):3717-32. PMID: 26179962.
      View in: PubMed
    9. Kim JI, Long JD, Mills JA, McCusker E, Paulsen JS. Multivariate clustering of progression profiles reveals different depression patterns in prodromal Huntington disease. Neuropsychology. 2015 Nov; 29(6):949-60. PMID: 26011117.
      View in: PubMed
    10. Fink KD, Deng P, Torrest A, Stewart H, Pollock K, Gruenloh W, Annett G, Tempkin T, Wheelock V, Nolta JA. Developing stem cell therapies for juvenile and adult-onset Huntington's disease. Regen Med. 2015; 10(5):623-46. PMID: 26237705.
      View in: PubMed
    11. Musso M, Westervelt HJ, Long JD, Morgan E, Woods SP, Smith MM, Lu W, Paulsen JS. Intra-individual Variability in Prodromal Huntington Disease and Its Relationship to Genetic Burden. J Int Neuropsychol Soc. 2015 Jan; 21(1):8-21. PMID: 26304055.
      View in: PubMed
    12. Koster DP, Higginson CI, MacDougall EE, Wheelock VL, Sigvardt KA. Subjective Cognitive Complaints in Parkinson Disease Without Dementia: A Preliminary Study. Appl Neuropsychol Adult. 2015; 22(4):287-92. PMID: 25495957.
      View in: PubMed
    13. Oskarsson B, Wheelock V, Benatar M, Taylor JP, Joyce N, Chesak D, Jin LW. A case of familial ALS due to multi-system proteinopathy 1 and Huntington disease. Amyotroph Lateral Scler Frontotemporal Degener. 2015 Mar; 16(1-2):124-6. PMID: 25205077.
      View in: PubMed
    14. Long JD, Paulsen JS, Marder K, Zhang Y, Kim JI, Mills JA. Tracking motor impairments in the progression of Huntington's disease. Mov Disord. 2014 Mar; 29(3):311-9. PMID: 24150908.
      View in: PubMed
    15. Goldenholz DM, Mehra N, Dahlin B, Cohen SH, Wheelock VL. Teaching neuroimages: fungus in the brain: coccidioidomycosis meningoencephalitis. Neurology. 2013 Feb 19; 80(8):e82. PMID: 23420900.
      View in: PubMed
    16. Aylward EH, Harrington DL, Mills JA, Nopoulos PC, Ross CA, Long JD, Liu D, Westervelt HK, Paulsen JS. Regional atrophy associated with cognitive and motor function in prodromal Huntington disease. J Huntingtons Dis. 2013; 2(4):477-89. PMID: 25062732.
      View in: PubMed
    17. Younes L, Ratnanather JT, Brown T, Aylward E, Nopoulos P, Johnson H, Magnotta VA, Paulsen JS, Margolis RL, Albin RL, Miller MI, Ross CA. Regionally selective atrophy of subcortical structures in prodromal HD as revealed by statistical shape analysis. Hum Brain Mapp. 2014 Mar; 35(3):792-809. PMID: 23281100.
      View in: PubMed
    18. Brossman B, Williams JK, Downing N, Mills JA, Paulsen JS. Development of the Huntington disease work function scale. J Occup Environ Med. 2012 Oct; 54(10):1300-8. PMID: 22995807.
      View in: PubMed
    19. Goldenholz DM, Wong VS, Bateman LM, Apperson M, Oskarsson B, Akhtar S, Wheelock V. Treatment of ?-aminobutyric acid B receptor-antibody autoimmune encephalitis with oral corticosteroids. Arch Neurol. 2012 Aug; 69(8):1061-3. PMID: 22507884.
      View in: PubMed
    20. Harrington DL, Smith MM, Zhang Y, Carlozzi NE, Paulsen JS. Cognitive domains that predict time to diagnosis in prodromal Huntington disease. J Neurol Neurosurg Psychiatry. 2012 Jun; 83(6):612-9. PMID: 22451099.
      View in: PubMed
    21. Long JD, Matson WR, Juhl AR, Leavitt BR, Paulsen JS. 8OHdG as a marker for Huntington disease progression. Neurobiol Dis. 2012 Jun; 46(3):625-34. PMID: 22414782.
      View in: PubMed
    22. Olson SD, Pollock K, Kambal A, Cary W, Mitchell GM, Tempkin J, Stewart H, McGee J, Bauer G, Kim HS, Tempkin T, Wheelock V, Annett G, Dunbar G, Nolta JA. Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's disease. Mol Neurobiol. 2012 Feb; 45(1):87-98. PMID: 22161544.
      View in: PubMed
    23. Higginson CI, Wheelock VL, Levine D, Pappas CT, Sigvardt KA. Predictors of HVOT performance in Parkinson's disease. Appl Neuropsychol. 2011 Jul; 18(3):210-5. PMID: 21846220.
      View in: PubMed
    24. Wong VS, Adamczyk P, Dahlin B, Richman DP, Wheelock V. Cerebral venous sinus thrombosis presenting with auditory hallucinations and illusions. Cogn Behav Neurol. 2011 Mar; 24(1):40-2. PMID: 21467920.
      View in: PubMed
    25. Paulsen JS, Wang C, Duff K, Barker R, Nance M, Beglinger L, Moser D, Williams JK, Simpson S, Langbehn D, van Kammen DP. Challenges assessing clinical endpoints in early Huntington disease. Mov Disord. 2010 Nov 15; 25(15):2595-603. PMID: 20623772.
      View in: PubMed
    26. Williams JK, Erwin C, Juhl AR, Mengeling M, Bombard Y, Hayden MR, Quaid K, Shoulson I, Taylor S, Paulsen JS. In their own words: reports of stigma and genetic discrimination by people at risk for Huntington disease in the International RESPOND-HD study. Am J Med Genet B Neuropsychiatr Genet. 2010 Sep; 153B(6):1150-9. PMID: 20468062.
      View in: PubMed
    27. Soneson C, Fontes M, Zhou Y, Denisov V, Paulsen JS, Kirik D, Petersén A. Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis. Neurobiol Dis. 2010 Dec; 40(3):531-43. PMID: 20682340.
      View in: PubMed
    28. Erwin C, Williams JK, Juhl AR, Mengeling M, Mills JA, Bombard Y, Hayden MR, Quaid K, Shoulson I, Taylor S, Paulsen JS. Perception, experience, and response to genetic discrimination in Huntington disease: the international RESPOND-HD study. Am J Med Genet B Neuropsychiatr Genet. 2010 Jul; 153B(5):1081-93. PMID: 20468061.
      View in: PubMed
    29. Randomized controlled trial of ethyl-eicosapentaenoic acid in Huntington disease: the TREND-HD study. Arch Neurol. 2008 Dec; 65(12):1582-9. PMID: 19064745.
      View in: PubMed
    30. Higginson CI, Wheelock VL, Levine D, King DS, Pappas CT, Sigvardt KA. The clinical significance of neuropsychological changes following bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease. J Clin Exp Neuropsychol. 2009 Jan; 31(1):65-72. PMID: 18608676.
      View in: PubMed
    31. Higginson CI, Wheelock VL, Levine D, King DS, Pappas CT, Sigvardt KA. Cognitive deficits in essential tremor consistent with frontosubcortical dysfunction. J Clin Exp Neuropsychol. 2008 Oct; 30(7):760-5. PMID: 18608666.
      View in: PubMed
    32. Langbehn DR, Paulsen JS. Predictors of diagnosis in Huntington disease. Neurology. 2007 May 15; 68(20):1710-7. PMID: 17502553.
      View in: PubMed
    33. Higginson CI, Wheelock VL, Carroll KE, Sigvardt KA. Recognition memory in Parkinson's disease with and without dementia: evidence inconsistent with the retrieval deficit hypothesis. J Clin Exp Neuropsychol. 2005 May; 27(4):516-28. PMID: 15962695.
      View in: PubMed
    34. Hogarth P, Kayson E, Kieburtz K, Marder K, Oakes D, Rosas D, Shoulson I, Wexler NS, Young AB, Zhao H. Interrater agreement in the assessment of motor manifestations of Huntington's disease. Mov Disord. 2005 Mar; 20(3):293-7. PMID: 15584032.
      View in: PubMed
    35. Shook SK, Franz EA, Higginson CI, Wheelock VL, Sigvardt KA. Dopamine dependency of cognitive switching and response repetition effects in Parkinson's patients. Neuropsychologia. 2005; 43(14):1990-9. PMID: 16243049.
      View in: PubMed
    36. Hurtado JM, Rubchinsky LL, Sigvardt KA, Wheelock VL, Pappas CT. Temporal evolution of oscillations and synchrony in GPi/muscle pairs in Parkinson's disease. J Neurophysiol. 2005 Mar; 93(3):1569-84. PMID: 15496492.
      View in: PubMed
    37. Higginson CI, King DS, Levine D, Wheelock VL, Khamphay NO, Sigvardt KA. The relationship between executive function and verbal memory in Parkinson's disease. Brain Cogn. 2003 Aug; 52(3):343-52. PMID: 12907179.
      View in: PubMed
    38. Wheelock VL, Tempkin T, Marder K, Nance M, Myers RH, Zhao H, Kayson E, Orme C, Shoulson I. Predictors of nursing home placement in Huntington disease. Neurology. 2003 Mar 25; 60(6):998-1001. PMID: 12654967.
      View in: PubMed
    Vicki L's Networks
    Concepts
    Derived automatically from this person's publications.
    See all (197) concept(s)
    _
    Co-Authors
    People in Profiles who have published with this person.
    See all (25) people
    _
    Similar People
    People who share similar concepts with this person.
    See all (60) people
    _
    Same Department
    Search Department
    ↑